Erratum: Atomoxetine Enhances Connectivity of Prefrontal Networks in Parkinson’s Disease

Correction to: Neuropsychopharmacology advance online publication, 2 March 2016; doi:10.1038/npp.2016.18 Following the publication of this paper, the authors have changed the Funding and Disclosure section to read as follows: This work was funded by the Wellcome trust (103838), Parkinson’s UK, National Institute for Health Research’s Cambridge Biomedical Research Centre and the Medical Research Council (MC_US_A060_0016 and RG62761), and the James F McDonnell Foundation (21st century science initiative on Understanding Human Cognition).